Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Contemporary Clinical Trials|January 12, 2011
Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialKenneth W Mahaffey, June L Wampole, Amanda Stebbins, et al.
European Heart Journal. Acute Cardiovascular Care|July 1, 2021
Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profileEhsan Khan, Kristina Lambrakis, Andrew Blyth, et al.
American Heart Journal|January 7, 2003
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarctionJohn K French, Neil S Van de Water, Timothy M Sutton, et al.
American Heart Journal|November 4, 2004
Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trialHarvey D White, Sebastian T Palmeri, Lynn A Sleeper, et al.
Journal of the American College of Cardiology|February 6, 1999
Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flowJ K French, D J Amos, B F Williams, et al.
The Medical Journal of Australia|January 16, 2015
Availability of highly sensitive troponin assays and acute coronary syndrome care: insights from the SNAPSHOT registryLouise Cullen, John K French, Tom G Briffa, et al.
The Medical Journal of Australia|October 30, 2015
Survival after an acute coronary syndrome: 18-month outcomes from the Australian and New Zealand SNAPSHOT ACS studyDavid B Brieger, Derek P B Chew, Julie Redfern, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 24, 2017
High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI studyRichard Nowak, Christian Mueller, Evangelos Giannitsis, et al.
Pageof 30